Brief: Tcr² Therapeutics Appoints Industry And Finance Veteran Eric Sullivan As Chief Financial Officer
27/06/2022 12:08
June 27 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS APPOINTS INDUSTRY AND FINANCE VETERAN
ERIC
SULLIVAN AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNX1tpfm3
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview